Zedsen, founded in 2015 and headquartered in the United Kingdom, is pioneering the field of non-invasive technology with its proprietary sensor designed to improve health and oncological care. The company aligns with the Institute for Healthcare Improvement’s “Triple Aim”, focused on enhancing the quality of care, improving patient health outcomes, and reducing healthcare costs.
Specializing across Biotechnology, Health Care, and Lifestyle industries, Zedsen presents a compelling proposition for transforming healthcare delivery. Their innovative approach has attracted notable investments, including a $12.00M Series B round completed on 06 April 2021. Prominent investors such as Tony Rice, Nasser J. Kazeminy, James W. Harpel, Bonnie McElveen Hunter, and Joseph Grano have backed the company, reflecting strong confidence in its potential to revolutionize the market.